EUVIMEDEUVIMED entdecken
Crossref

Study on Quality Evaluation of Processed Cimicifuga Rhizoma Based on UPLC Fingerprint and Chemometrics

Lihua Tan, Na Li, Guoqin Zhang, Zhenyu Zhou, Yanan Liu iD, Meng Wang, Xiaoliang Ren iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Lihua Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Cimicifuga, Drugs, Chinese Herbal. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cimicifuga Rhizoma, a traditional Chinese medicinal herb for treating toothache, aphtha, and measles, is also used as a dietary supplement for menopausal and osteoporosis management. Its therapeutic variability hinges on diverse processing methods, yet systematic quality assessment remains elusive. Here, nine processed Cimicifuga products were prepared following pharmacopoeia and classical protocols. Ultra‐high performance liquid chromatography (UPLC) fingerprints integrated with multivariate chemometrics‐hierarchical clustered heatmap (HCH), principal component analysis (PCA), and orthogonal partial least squares‐discriminant analysis (OPLS‐DA) revealed three distinct clusters. Variable importance projection (VIP > 1) identified caffeic acid, ferulic acid, and isoferulic acid as key markers. Quantitative analysis demonstrated that heating temperature and duration critically influenced these phenolic acids: steaming significantly increased all three, with caffeic acid, ferulic acid, and isoferulic acid contents rising by 1.71‐, 1.27‐, and 1.02‐fold, respectively, whereas carbonization selectively elevated isoferulic acid by 3.03‐fold. This chemometric‐driven approach establishes a simplified yet robust framework for quality evaluation, linking processing parameters (e.g., thermal conditions) to chemical profiles. By bridging traditional processing knowledge with modern analytical rigor, the study provided actionable insights for standardizing Cimicifuga Rhizoma derivatives in clinical and industrial contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CimicifugaDrugs, Chinese HerbalChromatography, High Pressure LiquidChemometricsCaffeic AcidsPrincipal Component AnalysisRhizomeCoumaric AcidsQuality Control

Stichwörter der Autor:innen

Cimicifuga RhizomaUPLC fingerprintchemometricsprocessingquality control

Substanzen

Drugs, Chinese HerbalCaffeic AcidsCoumaric Acidscaffeic acidferulic acid

Autor:innen und Institutionen

  • State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

ORCID-Profile: Yanan Liu, Xiaoliang Ren

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tan, L., Li, N., Zhang, G., Zhou, Z., Liu, Y., Wang, M., & Ren, X. (2025). Study on Quality Evaluation of Processed Cimicifuga Rhizoma Based on UPLC Fingerprint and Chemometrics. Biomedical Chromatography. https://doi.org/10.1002/bmc.70141

Vancouver

Tan L, Li N, Zhang G, Zhou Z, Liu Y, Wang M, et al. Study on Quality Evaluation of Processed Cimicifuga Rhizoma Based on UPLC Fingerprint and Chemometrics. Biomedical Chromatography. 2025. doi:10.1002/bmc.70141

BibTeX
@article{Tan2025,
  author = {Tan, Lihua and Li, Na and Zhang, Guoqin and Zhou, Zhenyu and Liu, Yanan and Wang, Meng and Ren, Xiaoliang},
  title = {Study on Quality Evaluation of Processed Cimicifuga Rhizoma Based on UPLC Fingerprint and Chemometrics},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70141}
}
Kostenlos starten →